Building Better Antibodies with John Williams, Ph.D.

April 19, 2018 | Katie Neith

Researchers at Beckman Research Institute of City of Hope use novel technology to add new functionalities to already potent proteins.

Continue Reading

Research Grant Roundup

June 4, 2018 | City of Hope

Review the latest City of Hope grant awardees.

$2 million grant awarded to City of Hope to promote critical research on aging and cancer

June 1, 2018 | Letisia Marquez

The National Institute of Aging has awarded $2 million to City of Hope to establish a national research infrastructure that will facilitate and support significant innovative projects across the country addressing aging and cancer.

Looking Ahead: A Conversation with Steven T. Rosen, M.D., Provost and Chief Scientific Officer

May 30, 2018 | Michael Easterling

Steven T. Rosen, M.D., just marked his fourth year at City of Hope as provost and chief scientific officer. On the occasion of his first four years at City of Hope and the recent five-year renewal of a National Cancer Institute grant, we sat down with Rosen to reflect on his time at City of Hope.

Stephen Forman, M.D., Inducted into AAP

May 30, 2018 | Michael Easterling

Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.

Jianjun Chen, Ph.D., Takes Aim at Acute Myeloid Leukemia

May 15, 2018 | City of Hope

Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about acute myeloid leukemia (AML), one of the most common and deadly forms of blood cancer.

City of Hope's Physician-in-Chief Michael Caligiuri Named AACR Fellow

May 14, 2018 | City of Hope

City of Hope President and Physician-in-Chief Michael A. Caligiuri, M.D., has been named a 2018 Fellow of the American Association for Cancer Research’s AACR Academy.

New Scientist dedicates much of his research program to acute myeloid leukemia

February 27, 2018 | Katie Neith

Jianjun Chen, Ph.D.'s, long-term goal is to further advance the understanding of cancer biology, and AML in particular, and to translate the discoveries from basic research into clinical application.

New Hire: Farah R. Abdulla, M.D.

January 25, 2018 | City of Hope

Farah Abdulla, M.D., specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin.